Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case–control study

Abstract

Genetic risk factors for ticlopidine-induced hepatotoxicity were determined in 22 Japanese patients with ticlopidine-induced hepatotoxicity and 85 Japanese patients who tolerated ticlopidine therapy without experiencing adverse reactions. There was a significant correlation between ticlopidine-induced hepatotoxicity and five human leukocyte antigen (HLA) alleles: HLA-A*3303, HLA-B*4403, HLA-Cw*1403, HLA-DRB1*1302 and HLA-DQB1*0604 (corrected probability (P)-value (Pc)<0.01). In particular HLA-A*3303 was present in 15 (68%) of the 22 patients with ticlopidine-induced hepatotoxicity and in 12 (14%) of the 85 ticlopidine-tolerant patients (odds ratio, 13.04; 95% confidence interval (CI), 4.40–38.59; the corrected P-value (Pc)=1.24 × 10–5). HLA-A*3303 was present in 12 (86%) of the 14 patients with ticlopidine-induced cholestatic hepatotoxicity (odds ratio, 36.50; 95% CI, 7.25–183.82, Pc=7.32 × 10–7). Ticlopidine-induced severe cholestatic hepatotoxicity occurred more frequently in subjects with HLA-A*3303 and its haplotype in Japanese patients. These findings may explain the high incidence of ticlopidine-induced hepatotoxicity in Japanese patients mediated via an immune-mediated mechanism.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Jacobson AK . Platelet ADP receptor antagonists: ticlopidine and clopidogrel. Best Pract Res Clin Hematol 2004; 17: 55–64.

    Article  CAS  Google Scholar 

  2. Takikawa H . Lessons from ticlopidine-induced liver injury. Hepatol Res 2005; 33: 193–194.

    Article  PubMed  Google Scholar 

  3. Mizushima M, Iwata N, Fujimoto TT, Ishikawa K, Fujimura K . Patients characteristics in ticlopidine hydrochloride-induced liver injury: case–control study. Hepatol Res 2005; 33: 234–240.

    Article  CAS  PubMed  Google Scholar 

  4. Veldhuyzen van Zanten SJO, McCormick CW . Antinuclear antibody-positive ticlopidine-induced hepatitis. Can J Gastroenterol 1996; 10: 231–232.

    Article  Google Scholar 

  5. Tsai M-H, Tsai S-L, Chen T-C, Liaw Y-F . Ticlopidine-induced cholestatic hepatitis with anti-nuclear antibody in serum. J Formos Med Assoc 2000; 99: 866–869.

    CAS  PubMed  Google Scholar 

  6. Tsutsui H, Terano Y, Sakagami C, Hasegawa I, Mizoguchi Y, Morisawa S . Drug-specific T cells derived from patients with drug-induced allergic hepatitis. J Immunol 1992; 149: 706–716.

    CAS  PubMed  Google Scholar 

  7. Kalgutkar AS, Gardner I, Obach RS, Shaffer CL, Callegari E, Henne KR et al. A comprehensive listing of bioactivation pathways of organic functional groups. Curr Drug Metab 2005; 6: 161–225.

    Article  CAS  PubMed  Google Scholar 

  8. López Garcia MP, Dansette PM, Valadon P, Amar C, Beaune PH, Gueng-Erich FP et al. Human-liver cytochrome P-450 expressed in yeast as tools for reactive-metabolite formation studies. Oxidative activation of tienilic acid by cytochrome P-450 2C9 and 2C10. Eur J Biochem 1993; 213: 223–232.

    Article  PubMed  Google Scholar 

  9. López-Garcia MP, Dansette MP, Mansuy D . Thiophene derivatives as new mechanism-based inhibitors of cytochromes P-450: inactivation of yeast-expressed human liver cytochrome P-450 2C9 by tienilic acid. Biochemistry 1994; 33: 166–175.

    Article  PubMed  Google Scholar 

  10. Dansette PM, Bonierbale E, Minoletti C, Beaune PH, Pessayre D, Mansuy D . Drug-induced immunotoxicity. Eur J Drug Metab Pharmacokinet 1998; 23: 443–451.

    Article  CAS  PubMed  Google Scholar 

  11. Kaplowitz N, DeLeve LD . Drug-Induced Liver Disease. Marcel Dekker: New York, 2003.

    Google Scholar 

  12. Ieiri I, Kimura M, Irie S, Urae A, Otsubo K, Ishizaki T . Interaction magnitude, pharmacokinetics and pharmacodynamics of ticlopidine in relation to CYP2C19 genotypic status. Pharmacogenet Genom 2005; 15: 851–859.

    Article  CAS  Google Scholar 

  13. Tateishi T, Kumai T, Watanabe M, Nakura H, Tanaka M, Kobayashi S . Ticlopidine decreases the in vivo activity of CYP2C19 as measured by omeprazole metabolism. Br J Clin Pharmacol 1999; 47: 454–457.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ha-Duong N-T, Dijols S, Macherey A-C, Goldstein JA, Dansette PM, Mansuy D . Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19. Biochemistry 2001; 40: 12112–12122.

    Article  CAS  PubMed  Google Scholar 

  15. Richter T, Mürdter TE, Heinkele G, Pleiss J, Tatzel S, Schwab M et al. Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine. J Pharmacol Exp Ther 2004; 308: 189–197.

    Article  CAS  PubMed  Google Scholar 

  16. Turpeinen M, Tolonen A, Uusitalo J, Jalonen J, Pelkonen O, Laine K . Effect of clopidogrel and ticlopidine on cytochrome P450 2B6 activity as measured by bupropion hydroxylation. Clin Pharmacol Ther 2005; 77: 553–559.

    Article  CAS  PubMed  Google Scholar 

  17. Ko JW, Desta Z, Soukhova NV, Tracy T, Flockhart DA . In vitro inhibition of the cytochrome P450 (CYP450) system by the antiplatelet drug ticlopidine: potent effect on CYP2C19 and CYP2D6. Br J Clin Pharmacol 2000; 49: 343–351.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Boissonnat P, de Lorgeril M, Perroux V, Salen P, Batt AM, Barthelemy JC et al. A drug interaction study between ticlopidine and cyclosporin in heart transplant recipients. Eur J Clin Pharmacol 1997; 53: 39–45.

    Article  CAS  PubMed  Google Scholar 

  19. Dreiem A, Fonnum F . Thiophene is toxic to cerebellar granule cells in culture after bioactivation by rat liver enzymes. Neuro Toxicol 2004; 25: 959–966.

    CAS  Google Scholar 

  20. Kurosaki M, Takagi H, Mori M . HLA-A33/B44/DR6 is highly related to intrahepatic cholestasis induced by tiopronin. Dig Dis Sci 2000; 45: 1103–1108.

    Article  CAS  PubMed  Google Scholar 

  21. Andrade RJ, Lucena MI, Alonso A, García-Cortes M, García-Ruiz E, Benitez R et al. HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease. Hepatology 2004; 39: 1603–1612.

    Article  CAS  PubMed  Google Scholar 

  22. O'Donohue J, Oien KA, Donaldson P, Underhill J, Clare M, MacSween RNM et al. Co-amoxiclav jaundice: clinical and histological features and HLA class II association. Gut 2000; 47: 717–720.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Berson A, Freneaux E, Larrey D, Lepage V, Douay C, Mallet C et al. Possible role of HLA in hepatotoxicity. An exploratory study in 71 patients with drug-induced idiosyncratic hepatitis. J Hepatol 1994; 20: 336–342.

    Article  CAS  PubMed  Google Scholar 

  24. Pirmohamed M . Genetic factors in the predisposition to drug-induced hypersensitivity reactions. J Am Assoc Pharm Sci 2006; 8: E20–E26.

    CAS  Google Scholar 

  25. Saito S, Ota S, Yamada E, Inoko H, Ota M . Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens 2000; 56: 522–529.

    Article  CAS  PubMed  Google Scholar 

  26. Cao K, Hollenbach J, Shi X, Shi W, Chopek M, Fernández-Viña MA . Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum Immunol 2001; 62: 1009–1030.

    Article  CAS  PubMed  Google Scholar 

  27. Danan G, Benichou C . Causality assessment of adverse reactions to drugs I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46: 1323–1330.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all of the patients who agreed to take part in this study. We also thank Dr Kingo Fujimura (Professor, Hiroshima University, Faculty of Medicine), Dr Takaaki Isshiki (Professor, Teikyo University, Department of Medicine), Dr Tsutomu Imaizumi (Professor, Kurume University School of Medicine), Dr Hideo Kusuoka (Vice Director, Osaka National Hospital), Dr Takahito Sone (Director, Ogaki Municipal Hospital), Dr Genki Mizukoshi (Nippon Medical School), Dr Masayuki Taniguchi (Associate Professor, Jikei University School of Medicine Daisan Hospital), Dr Satoshi Hirose (Assistant Professor, University of Fukui Hospital) and Dr Hiroyuki Takashima (Teaching Assistant, Shiga University of Medical Science) for patient recruitment and data collection, as well as Dr Masayuki Yamamoto (Professor, Center for Tsukuba Advanced Research Alliance), Dr Noritaka Ariyoshi (Associate Professor, Chiba University School of Medicine), ADME/TOX Research Institute of Daiichi Pure Chemicals Co., Ltd, and Mitsubishi Kagaku Bio-Clinical Laboratory Inc. for genotyping analyses.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K Hirata.

Additional information

Duality of Interest

This study was supported by Daiichi Pharmaceutical Co., Ltd.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hirata, K., Takagi, H., Yamamoto, M. et al. Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case–control study. Pharmacogenomics J 8, 29–33 (2008). https://doi.org/10.1038/sj.tpj.6500442

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.tpj.6500442

Keywords

This article is cited by

Search

Quick links